SALNACEDIN

Details

Stereochemistry	ABSOLUTE
Molecular Formula	C12H13NO5S
Molecular Weight	283.3
Optical Activity	UNSPECIFIED
Defined Stereocenters	1 / 1
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure Search

SMILES

CC(=O)N[C@@H](CSC(=O)C1=C(O)C=CC=C1)C(O)=O

InChI

InChIKey=VYPKEODFNOEZGS-VIFPVBQESA-N

InChI=1S/C12H13NO5S/c1-7(14)13-9(11(16)17)6-19-12(18)8-4-2-3-5-10(8)15/h2-5,9,15H,6H2,1H3,(H,13,14)(H,16,17)/t9-/m0/s1

HIDE SMILES / InChI

Description
Sources: https://adisinsight.springer.com/drugs/800006855

Salnacedin (also known as G 201) was developed as a topical anti-inflammatory agent; Salnacedin participated in phase II clinical trials in the USA for the treatment of dermatitis, acne, and psoriasis. However, all these studies were discontinued.

Originator

Approval Year

Patents

Sample Use Guides

In Vivo Use Guide

Unknown

Route of Administration: Topical

Name

Type

Language

SALNACEDIN

Official Name

English

N-ACETYL-L-CYSTEINE SALICYLATE (ESTER)

Common Name

English

G-201

Code

English

G-201SCY

Code

English

SALNACEDIN [INCI]

Common Name

English

SALNACEDIN [USAN]

Common Name

English

N-ACETYL-S-(2-HYDROXYBENZOYL)-CYSTEINE

Systematic Name

English

G-201,SCY

Code

English

SALNACEDIN [MART.]

Common Name

English

salnacedin [INN]

Common Name

English

Classification Tree Code System Code

NCI_THESAURUS

C275